1 Min Read
March 29 (Reuters) - Jilin Province Huinan Changlong Bio-Pharmacy Co Ltd:
* FY PROFIT ATTRIBUTABLE RMB144.4 MILLION VERSUS RMB142.7 MILLION Source text for Eikon: Further company coverage: